A detailed history of Allworth Financial LP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 957 shares of ADMA stock, worth $10,699. This represents 0.0% of its overall portfolio holdings.

Number of Shares
957
Previous 740 29.32%
Holding current value
$10,699
Previous $3,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$4.4 - $6.74 $954 - $1,462
217 Added 29.32%
957 $6,000
Q3 2022

Oct 18, 2022

BUY
$2.03 - $2.86 $1,502 - $2,116
740 New
740 $2,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $2.2B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.